PERSPECTA

News from every angle

← Back to headlines

Biohaven and Yale Win $4 Million Judgment in Trade Secret Misappropriation Case

A federal court has entered a judgment confirming that RA Capital and Avilar Therapeutics willfully and maliciously misappropriated a trade secret developed at Yale, formalizing a $4 million award to Biohaven and Yale University.

25 Aug, 20:41 — 25 Aug, 20:41
PostShare

Sources

Showing 1 of 2 sources
morningstar8h ago

Federal Court Enters Judgment Confirming RA Capital and Avilar Therapeutics Willfully and Maliciously Misappropriated Trade Secret Developed at Yale, Formalizing $4 Million Award to Biohaven and Yale University - Morningstar

Federal Court Enters Judgment Confirming RA Capital and Avilar Therapeutics Willfully and Maliciously Misappropriated Trade Secret Developed at Yale, Formalizing $4 Million Award to Biohaven and Yale University  Morningstar

Read full article →

Coverage Timeline

First report: morningstar · 25 Aug, 20:41Full coverage: 2 · 7mWindow: 7m
Left-leaningCenterRight-leaning
morningstar25 Aug, 20:41First to report

Federal Court Enters Judgment Confirming RA Capital and Avilar Therapeutics Willfully and Maliciously Misappropriated Trade Secret Developed at Yale, Formalizing $4 Million Award to Biohaven and Yale University - Morningstar

investing-com25 Aug, 20:48Latest update

Biohaven, Yale win $4M judgment in trade secret case

Related Stories

Honda Considers Halting New North American Plant Without Trade Deal Extension

28m ago

Drone Strike Causes Fire at Russian Oil Refinery

34m ago

SK Biopharmaceuticals Licenses Epilepsy Drug Candidate from Biohaven

53m ago

Shein Considers Hong Kong IPO Amid Slowing Growth and Regulatory Scrutiny

58m ago